Name (Synonyms) | Correlation | |
---|---|---|
drug766 | Standard Plasma (FFP) Wiki | 1.00 |
drug363 | Hydroxychloroquine + Placebo Wiki | 1.00 |
drug349 | High-Titer COVID-19 Convalescent Plasma (HT-CCP) Wiki | 1.00 |
drug618 | Placebo + Placebo Wiki | 1.00 |
Name (Synonyms) | Correlation | |
---|---|---|
D003141 | Communicable Diseases NIH | 0.12 |
D007239 | Infection NIH | 0.08 |
Name (Synonyms) | Correlation |
---|
There is one clinical trial.
Q-PROTECT is a placebo controlled randomized trial (RCT) to ascertain the efficacy of hydroxychloroquine (HC) alone or, in combination with azithromycin (AZ), in reducing viral load in patients with COVID 19.
Description: Days
Measure: Proportion of virologically cured (no virus detected) cases at day 6 Time: Day 6Description: Days
Measure: The dichotomous virologic shedding endpoint as assessed at two weeks after study entry Time: 2 weeksDescription: Days
Measure: Quantitative viral load (assessed with each virology testing set) Time: Day 1 to 21